comparemela.com
Home
Live Updates
Prnewswire Tikomed - Breaking News
Pages:
Latest Breaking News On - Prnewswire tikomed - Page 2 : comparemela.com
TikoMed s ILB® mobilizes and modulates key growth factors that trigger a cascade of neuroprotective mechanisms able to t
VIKEN, Sweden, Aug. 31, 2022 /PRNewswire/ TikoMed, a biopharmaceutical company focused on harnessing the.
Anders kristensson
Ann logan
Prnewswire tikomed
University of warwick
Scientific director
Axolotl consulting
Regenerative medicine
Amyotrophic lateral sclerosis
Traumatic brain injury
TikoMed s ILB® mobilizes and modulates key growth factors that trigger a cascade of neuroprotective mechanisms able to target all neuroinflammation-driven diseases including ALS
/PRNewswire/ TikoMed, a biopharmaceutical company focused on harnessing the medical potential of the body s ability to self-repair and regenerate, today.
Richard hayhurst
Anders kristensson
Ann logan
Prnewswire tikomed
University of warwick
Scientific director
Axolotl consulting
Regenerative medicine
Amyotrophic lateral sclerosis
Traumatic brain injury
vimarsana © 2020. All Rights Reserved.